ACE-031 Interactions & Stacking
ACE-031 has 2 documented interactions including 1 synergistic combinations for research stacking.
Interactions & Stacking Compatibility
| Peptide/Compound | Rating | Type | Description |
|---|---|---|---|
| Follistatin | ++ | synergistic | Both inhibit myostatin through different mechanisms (ligand trapping vs. direct binding). Conceptually synergistic, but no clinical data on combination use. |
| YK-11 | ~ | monitor | Both target the myostatin pathway. YK-11 acts as a myostatin inhibitor through a different mechanism. Combined use could produce excessive pathway suppression with unpredictable effects. |
Rating Legend
- ++ = Synergistic — Combined effect greater than individual
- + = Compatible — Safe to combine, additive benefits
- ~ = Monitor — Caution advised, dose adjustment may be needed
- avoid = Contraindicated — Do not combine
Related Sections
- Overview: What Is ACE-031?
Deep Dives: Key Benefits | Mechanism of Action | Research Indications | Dosing Protocols | Side Effects & Safety | What to Expect Timeline | FAQ | References & Studies | Quality Checklist
Product: ACE-031 — ≥98% (HPLC verified) · COA available · 1mg
Disclaimer: This compound is supplied for qualified research and laboratory purposes only. Not for human consumption, therapeutic use, or any application outside controlled research environments.
RaysunPeptide — Southeast Asia-based peptide manufacturer supplying research-grade compounds with HPLC/MS verification and Certificates of Analysis. B2B and qualified research applications.